Curian Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-36,540
Closed -$2.81M 235
2015
Q4
$2.81M Sell
36,540
-71,837
-66% -$5.41M 0.21% 106
2015
Q3
$7.25M Buy
108,377
+93,671
+637% +$6.9M 0.19% 127
2015
Q2
$1.09M Buy
14,706
+4,617
+46% +$353K 0.02% 447
2015
Q1
$787K Sell
10,089
-906
-8% -$68.7K 0.01% 512
2014
Q4
$794K Buy
10,995
+30
+0.3% +$2.08K 0.01% 497
2014
Q3
$679K Buy
10,965
+175
+2% +$11.1K 0.01% 509
2014
Q2
$688K Sell
10,790
-136
-1% -$8.26K 0.01% 511
2014
Q1
$672K Buy
10,926
+1,206
+12% +$70.2K 0.01% 509
2013
Q4
$558K Sell
9,720
-184
-2% -$10.4K 0.01% 491
2013
Q3
$527K Buy
9,904
+80
+0.8% +$4.3K 0.01% 498
2013
Q2
$506K Buy
+9,824
New +$486K 0.01% 483

Other funds holding MDT

Curian Capital's MDT Position: Q1 2016 in Review

Curian Capital sold out of Medtronic (MDT) in Q1 2016, closing a stake of 36,540 shares — an estimated $2.81M sold.

Curian Capital first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $7.25M in Q3 2015. 1,240 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

  • Curian Capital reported no remaining Medtronic position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 36,540 Medtronic shares in Q1 2016, an estimated $2.81M.
  • Curian Capital first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Medtronic position peaked at $7.25M in Q3 2015.
  • 1,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.